SCH 563705 is a potent, orally bioavailable dual antagonist of CXCR2 and CXCR1 chemokine receptors. It is a valuable research tool for investigating neutrophilic inflammation in models of acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD), both in vitro and in vivo.